Close Menu

An Analysis for Anxiety

Premium

Compared to other major psychiatric disorders like depression, schizophrenia, or bipolar disorder, generalized anxiety disorder — a category under which many anxiety-related disorders fall — is relatively understudied from a genomic standpoint.

The prevalence of these disorders, combined with the dearth of genomic data for them, led Indiana University School of Medicine's Alexander Niculescu to use an integrative, translational research approach to study anxiety disorders, with an eye toward developing personalized treatments.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The New York Times Magazine examines gender discrimination at the Salk Institute.

Science reports that MD Anderson Cancer Center has dismissed three researchers over foreign tie concerns.

A second death in gene therapy trial for type 1 spinal muscular atrophy is under investigation, according to Reuters.

In PLOS this week: antibiotic resistance patterns in Escherichia coli, a dozen genetic loci tied to varicose vein risk, and more.